In cervical cancer, a comprehensive bioinformatic analysis revealed that differential FNDC3B expression could distinguish between different stages of cervical cancer, with high FNDC3B expression indicating a shorter OS and DSS. This evidence concerns the gene FNDC3B and cervical cancer.